<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: GlaxoSmithKline (US) Trust -->
          <cik>0001999300</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001900304</issuerCik>
      <issuerName>Haleon plc</issuerName>
      <secFileNumber>001-41411</secFileNumber>
      <issuerAddress>
        <com:street1>BUILDING 5, FIRST FLOOR, THE HEIGHTS</com:street1>
        <com:city>WEYBRIDGE SURREY</com:city>
        <com:stateOrCountry>X0</com:stateOrCountry>
        <com:zipCode>KT13 0NY</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>44-1932-822-000</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>GlaxoSmithKline (US) Trust</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>American Depositary Shares, each representing two ordinary shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Citigroup Global Markets Inc</name>
        <address>
          <com:street1>388 Greenwich Street</com:street1>
          <com:street2>4th Floor Trading</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10013</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>8527104</noOfUnitsSold>
      <aggregateMarketValue>70604421.10</aggregateMarketValue>
      <noOfUnitsOutstanding>9234573831</noOfUnitsOutstanding>
      <approxSaleDate>12/27/2023</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>American Depositary Shares, each representing two ordinary shares</securitiesClassTitle>
      <acquiredDate>07/18/2022</acquiredDate>
      <natureOfAcquisitionTransaction>The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Haleon plc</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>8527104</amountOfSecuritiesAcquired>
      <paymentDate>07/18/2022</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>The Filer is not currently an affiliate of the Issuer, but was an affiliate during the preceding three months. The Number of Shares or Other Units Outstanding provided above represents the number of outstanding ordinary shares (and not American Depositary Shares).</remarks>
    <noticeSignature>
      <noticeDate>12/29/2023</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>11/03/2023</planAdoptionDate>
      </planAdoptionDates>
      <signature>/s/ Mark Le Saint</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3479}]
144
0001999300
XXXXXXXX
LIVE
0001900304
Haleon plc
001-41411
BUILDING 5, FIRST FLOOR, THE HEIGHTS
WEYBRIDGE SURREY
X0
KT13 0NY
44-1932-822-000
GlaxoSmithKline (US) Trust
Affiliate
American Depositary Shares, each representing two ordinary shares
Citigroup Global Markets Inc
388 Greenwich Street
4th Floor Trading
New York
NY
10013
8527104
70604421.10
9234573831
12/27/2023
NYSE
American Depositary Shares, each representing two ordinary shares
07/18/2022
The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc
Haleon plc
N
8527104
07/18/2022
N/A
Y
The Filer is not currently an affiliate of the Issuer, but was an affiliate during the preceding three months. The Number of Shares or Other Units Outstanding provided above represents the number of outstanding ordinary shares (and not American Depositary Shares).
12/29/2023
11/03/2023
/s/ Mark Le Saint